PROTECT-CH was designed as a UK-wide platform clinical trial to evaluate prophylactic treatments for COVID-19 in care home residents.
Due to the success of the UK COVID-19 vaccination programme, and other measures taken by care homes to reduce the spread of COVID-19, it became clear that the study would require many times more care homes and residents to evaluate prophylactic treatments than was assumed when designing the study. The study was deemed no longer feasible and was stopped after 10 months. No participants were consented or randomised.
All materials developed by the research team in setting up the study are available here.
PROTECT-CH was funded by the National Institute of Health Research. The views expressed are those of the authors and not necessarily those of the NIHR or the Department of Health and Social Care.